China Pharma Holding (STU:XQJ0) FCF Margin % : -42.70% (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. China Pharma Holding's Free Cash Flow for the three months ended in Mar. 2024 was €-0.54 Mil. China Pharma Holding's Revenue for the three months ended in Mar. 2024 was €1.26 Mil. Therefore, China Pharma Holding's FCF Margin % for the quarter that ended in Mar. 2024 was -42.70%.

As of today, China Pharma Holding's current FCF Yield % is 3.37%.

The historical rank and industry rank for China Pharma Holding's FCF Margin % or its related term are showing as below:

STU:XQJ0' s FCF Margin % Range Over the Past 10 Years
Min: -10.16 Med: -0.71 Max: 17.36
Current: 3.15

During the past 13 years, the highest FCF Margin % of China Pharma Holding was 17.36%. The lowest was -10.16%. And the median was -0.71%.

STU:XQJ0's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.29 vs STU:XQJ0: 3.15

China Pharma Holding FCF Margin % Historical Data

The historical data trend for China Pharma Holding's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding FCF Margin % Chart

China Pharma Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

4.32

-8.37

-7.14

-10.01

-10.16

China Pharma Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-74.88	-19.64	55.89	-1.01	-42.70

Competitive Comparison of China Pharma Holding's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Pharma Holding's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's FCF Margin % distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's FCF Margin % falls into.

China Pharma Holding FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

China Pharma Holding's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.653	/	6.429
	=	-10.16 %

China Pharma Holding's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.538	/	1.26
	=	-42.70 %

China Pharma Holding FCF Margin % Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Pharma Holding (STU:XQJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CPHI:USA

Address

Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216

Website

https://www.chinapharmaholdings.com

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines